Opens in a new tab

Proteomics CRO · Framingham, MA

Quantitative proteomics for drug discovery

TMT, DIA and targeted LC-MS, chemoproteomics and PTM profiling, run end to end in our own lab by the Gygi Lab-trained scientists who founded it.

Since 2015
thousands of projects delivered
6
Orbitrap mass spectrometers
48
samples per day on the Orbitrap Astral

Trusted by nearly all of the world’s largest pharmaceutical companies, and the newest biotechs. Featured by Thermo Fisher Scientific: read the case study

Services

Start with your question

What is my compound hitting?

Chemoproteomics: cysteine reactivity and target engagement.

Learn more

What does my degrader remove?

Degrader profiling: selectivity, kinetics and mechanism.

Learn more

What changed in my system?

Discovery proteomics by TMT or DIA, more than 13,000 protein groups.

Learn more

Which pathways are firing?

PTM proteomics: phosphorylation, ubiquitination, acetylation and others, site by site.

Learn more

Who does my protein work with?

Protein interactions, with isotype controls in the plex.

Learn more

How much target is there?

Targeted proteomics: custom PRM assays with heavy standards.

Learn more

Eight services, from discovery to targeted assays. View all services

Chemoproteomics

Find the target. Rule out the false hits.

In a public study of sotorasib in H358 cells, our global cysteine profiling showed the KRAS G12C peptide disappearing with dose while KRAS protein held steady: engagement, not degradation. A companion proteome from the same samples exposed an apparent off-target hit as a change in protein level. Targeted assays then resolved engagement above 99%.

Explore chemoproteomics
Bar charts of KRAS G12C peptide falling and KRAS protein flat across six sotorasib doses in triplicate.
The KRAS G12C peptide falls with sotorasib dose while KRAS protein stays flat. Baltier et al., AACR 2025.

Why IQ Proteomics

Rigor, in one lab, for drug discovery

Gygi Lab rigor

Our founders trained together in the Harvard Medical School lab where foundational TMT methods were developed, and they still run the science.

Meet our leadership

One lab, end to end

Sample preparation, cell culture and LC-MS on six Orbitrap instruments, all in our Framingham laboratory. No subcontracting, no hand-offs.

See our facilities

Built for drug discovery

From target identification to IND-enabling engagement assays, with methods that carry across every stage of a program.

Explore services

Three routes, one platform

The right measurement for each stage

Programs often move from DIA screening, to precise TMT validation, to targeted PRM as candidates mature. Because all three share the same sample preparation and informatics, a project can switch route without restarting.

48/day
by DIA on the Orbitrap Astral
0
missing values within a TMT plex
>99%
target engagement resolved by PRM

Evidence

Proof in published work

Case study · Thermo Fisher Scientific 2026

A conversation with IQ Proteomics on TMT, DIA and PRM quantitation in drug discovery proteomics

Read the news post

Publications

Research built on our data

Thirty peer-reviewed papers draw on data from our laboratory. Browse publications

Technical notes

Our workflows, on real samples

Example datasets for each of our core workflows. Browse technical notes

Explore everything on our Reference page. Visit the Reference page

Ready to discuss your project?

Tell us about your samples, timeline and scientific goals, and one of our founders will be part of the conversation.